FR3002846B1 - Utilisation de souches attenuees de parasite pour la prevention et/ou le traitement de lesions oculaires associees a une infection par toxoplasma gondii - Google Patents

Utilisation de souches attenuees de parasite pour la prevention et/ou le traitement de lesions oculaires associees a une infection par toxoplasma gondii

Info

Publication number
FR3002846B1
FR3002846B1 FR1351999A FR1351999A FR3002846B1 FR 3002846 B1 FR3002846 B1 FR 3002846B1 FR 1351999 A FR1351999 A FR 1351999A FR 1351999 A FR1351999 A FR 1351999A FR 3002846 B1 FR3002846 B1 FR 3002846B1
Authority
FR
France
Prior art keywords
parasite
prevention
treatment
toxoplasma gondii
lesions associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1351999A
Other languages
English (en)
Other versions
FR3002846A1 (fr
Inventor
Poisson Isabelle Dimier
Gildas Lemee
Solen Morisse
Edouard Seche
Naoual Tarfaoui
Emre Yurdusev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VITAMFERO
Universite de Tours
Original Assignee
VITAMFERO
Universite Francois Rabelais de Tours
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VITAMFERO, Universite Francois Rabelais de Tours filed Critical VITAMFERO
Priority to FR1351999A priority Critical patent/FR3002846B1/fr
Priority to BR112015021805A priority patent/BR112015021805A2/pt
Priority to EP14713217.9A priority patent/EP2964239A1/fr
Priority to US14/773,560 priority patent/US20160017275A1/en
Priority to PCT/FR2014/050505 priority patent/WO2014135803A1/fr
Publication of FR3002846A1 publication Critical patent/FR3002846A1/fr
Application granted granted Critical
Publication of FR3002846B1 publication Critical patent/FR3002846B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/68—Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • C12N1/105—Protozoal isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/90—Protozoa ; Processes using protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR1351999A 2013-03-06 2013-03-06 Utilisation de souches attenuees de parasite pour la prevention et/ou le traitement de lesions oculaires associees a une infection par toxoplasma gondii Expired - Fee Related FR3002846B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR1351999A FR3002846B1 (fr) 2013-03-06 2013-03-06 Utilisation de souches attenuees de parasite pour la prevention et/ou le traitement de lesions oculaires associees a une infection par toxoplasma gondii
BR112015021805A BR112015021805A2 (pt) 2013-03-06 2014-03-05 uso de parasita stem atenuada para a prevenção e / ou tratamento das lesões oculares infecção associada toxoplasma gondii
EP14713217.9A EP2964239A1 (fr) 2013-03-06 2014-03-05 Utilisation de souches attenuees de parasite pour la prevention et/ou le traitement de lesions oculaires associees a une infection par toxoplasma gondii
US14/773,560 US20160017275A1 (en) 2013-03-06 2014-03-05 Use of attenuated parasite strains for the prevention and/or treatment of eye wounds associated with an infection by toxoplasma gondii
PCT/FR2014/050505 WO2014135803A1 (fr) 2013-03-06 2014-03-05 Utilisation de souches attenuees de parasite pour la prevention et/ou le traitement de lesions oculaires associees a une infection par toxoplasma gondii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1351999A FR3002846B1 (fr) 2013-03-06 2013-03-06 Utilisation de souches attenuees de parasite pour la prevention et/ou le traitement de lesions oculaires associees a une infection par toxoplasma gondii

Publications (2)

Publication Number Publication Date
FR3002846A1 FR3002846A1 (fr) 2014-09-12
FR3002846B1 true FR3002846B1 (fr) 2016-03-25

Family

ID=48613849

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1351999A Expired - Fee Related FR3002846B1 (fr) 2013-03-06 2013-03-06 Utilisation de souches attenuees de parasite pour la prevention et/ou le traitement de lesions oculaires associees a une infection par toxoplasma gondii

Country Status (5)

Country Link
US (1) US20160017275A1 (fr)
EP (1) EP2964239A1 (fr)
BR (1) BR112015021805A2 (fr)
FR (1) FR3002846B1 (fr)
WO (1) WO2014135803A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3068363A1 (fr) * 2017-07-03 2019-01-04 Vitamfero Utilisation de souches de sarcocystidae dans la prevention de maladies infectieuses de la volaille

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2864966B1 (fr) 2004-01-13 2006-05-05 Agronomique Inst Nat Rech Souches vaccinales d'apicomplexes de la famille des sarcocystidae.
JP4183095B2 (ja) 2006-04-27 2008-11-19 株式会社オーバル 渦流量計

Also Published As

Publication number Publication date
FR3002846A1 (fr) 2014-09-12
BR112015021805A2 (pt) 2017-07-18
US20160017275A1 (en) 2016-01-21
EP2964239A1 (fr) 2016-01-13
WO2014135803A1 (fr) 2014-09-12

Similar Documents

Publication Publication Date Title
HK1252786A1 (zh) 包含5-苯氧基-3h-嘧啶-4-酮衍生物的組合物及其用於預防或治療hiv感染的方法
HK1219480A1 (zh) 用於治療和預防乙型肝炎病毒感染的新的 -橋連的雜芳基二氫嘧啶
HK1223616A1 (zh) 多環氨基甲酰基吡啶酮化合物和其用於治療 感染的用途
HK1223615A1 (zh) 多環氨基甲酰基吡啶酮化合物和其用於治療 感染的用途
CL2016000424A1 (es) Métodos y composiciones para el arn-guiado tratamiento de la infección por vih
MA40008A (fr) Antagoniste actrii pour le traitement et la prevention d'un ulcere cutane chez un sujet ayant l'anemie
HK1203944A1 (zh) 用於治療和預防乙型肝炎病毒感染的 -甲基-二氫嘧啶類
HK1218071A1 (zh) 在預防和治療眼滲透性過高症中的抑制
FR2999191B1 (fr) Souches probiotiques pour le traitement et/ou la prevention de la diarrhee
FR3000895B1 (fr) Utilisation d'antidotes d'inhibiteurs de la coagulation indiques dans la prevention ou le traitement de pathologies thromboemboliques
FR2994096B1 (fr) Utilisation de souches attenuees de parasites pour la prevention ou le traitement de pathologies associees a un apicomplexe
EP2895511A4 (fr) Utilisation d'anticorps pour traiter une infection par le vih et supprimer la transmission du vih
FR3002846B1 (fr) Utilisation de souches attenuees de parasite pour la prevention et/ou le traitement de lesions oculaires associees a une infection par toxoplasma gondii
FR3017536B1 (fr) Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
FR3012859B1 (fr) "differentiel de transmission comportant des rondelles de friction munies de moyens indicateurs de presence"
FR3000399B1 (fr) Utilisation topique du laropiprant pour le traitement de la rosacee
FR3003761B1 (fr) Utilisation d'une lactone macrocyclique pour le traitement d'une infection par un papillomavirus
FR2982488B1 (fr) Urotensine ii pour son utilisation dans le traitement et/ou la prevention de pathologies impliquant la motilite gastrique

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

ST Notification of lapse

Effective date: 20171130